Impact	0	5
of	7	8
intracranial	10	21
pressure	23	30
monitor	32	38
prophylaxis	40	50
on	52	53
central	55	61
nervous	63	69
system	71	76
infections	78	87
and	89	91
bacterial	93	101
multi	103	107
-	108	108
drug	109	112
resistance	114	123
.	124	124

Routine	126	132
intracranial	134	145
pressure	147	154
monitor	156	162
(	164	164
ICP	165	167
)	168	168
prophylaxis	170	180
is	182	183
not	185	187
practiced	189	197
at	199	200
our	202	204
institution	206	216
.	217	217

Nevertheless	219	230
,	231	231
some	233	236
patients	238	245
receive	247	253
de	255	256
facto	258	262
prophylaxis	264	274
as	276	277
a	279	279
result	281	286
of	288	289
the	291	293
use	295	297
of	299	300
antibiotics	302	312
for	314	316
injuries	318	325
such	327	330
as	332	333
open	335	338
or	340	341
facial	343	348
fractures	350	358
.	359	359

We	361	362
tested	364	369
the	371	373
hypothesis	375	384
that	386	389
prophylactic	391	402
antibiotics	404	414
do	416	417
not	419	421
reduce	423	428
the	430	432
incidence	434	442
of	444	445
central	447	453
nervous	455	461
system	463	468
(	470	470
CNS	471	473
)	474	474
infections	476	485
but	487	489
instead	491	497
are	499	501
associated	503	512
with	514	517
the	519	521
acquisition	523	533
of	535	536
multi	538	542
-	543	543
drug	544	547
resistant	549	557
(	559	559
MDR	560	562
)	563	563
bacterial	565	573
infections	575	584
.	585	585

Patients	587	594
admitted	596	603
to	605	606
the	608	610
trauma	612	617
intensive	619	627
care	629	632
unit	634	637
(	639	639
TICU	640	643
)	644	644
from	646	649
January	651	657
,	658	658
2001	660	663
through	665	671
December	673	680
,	681	681
2004	683	686
with	688	691
blunt	693	697
,	698	698
non	700	702
-	703	703
operative	704	712
traumatic	714	722
brain	724	728
injury	730	735
who	737	739
were	741	744
managed	746	752
solely	754	759
with	761	764
an	766	767
ICP	769	771
monitor	773	779
were	781	784
identified	786	795
from	797	800
our	802	804
trauma	806	811
registry	813	820
and	822	824
divided	826	832
into	834	837
two	839	841
groups	843	848
:	849	849
(	851	851
1	852	852
)	853	853
Those	855	859
receiving	861	869
no	871	872
antibiotics	874	884
prior	886	890
to	892	893
or	895	896
during	898	903
ICP	905	907
monitoring	909	918
(	920	920
NONE	921	924
;	925	925
n	927	927
=	929	929
71	931	932
)	933	933
;	934	934
and	936	938
(	940	940
2	941	941
)	942	942
those	944	948
already	950	956
receiving	958	966
antibiotics	968	978
at	980	981
the	983	985
time	987	990
of	992	993
ICP	995	997
monitor	999	1005
insertion	1007	1015
(	1017	1017
PRO	1018	1020
;	1021	1021
n	1023	1023
=	1025	1025
84	1027	1028
)	1029	1029
.	1030	1030

Groups	1032	1037
were	1039	1042
stratified	1044	1053
on	1055	1056
the	1058	1060
basis	1062	1066
of	1068	1069
age	1071	1073
,	1074	1074
Injury	1076	1081
Severity	1083	1090
Score	1092	1096
(	1098	1098
ISS	1099	1101
)	1102	1102
,	1103	1103
Glasgow	1105	1111
Coma	1113	1116
Scale	1118	1122
(	1124	1124
GCS	1125	1127
)	1128	1128
Score	1130	1134
,	1135	1135
base	1137	1140
excess	1142	1147
(	1149	1149
BE	1150	1151
)	1152	1152
,	1153	1153
ICP	1155	1157
days	1159	1162
,	1163	1163
transfusions	1165	1176
in	1178	1179
24	1181	1182
h	1184	1184
,	1185	1185
ICU	1187	1189
days	1191	1194
,	1195	1195
ventilator	1197	1206
days	1208	1211
,	1212	1212
head	1214	1217
Abbreviated	1219	1229
Injury	1231	1236
Score	1238	1242
(	1244	1244
AIS	1245	1247
)	1248	1248
,	1249	1249
and	1251	1253
chest	1255	1259
AIS	1261	1263
.	1264	1264

The	1266	1268
study	1270	1274
groups	1276	1281
did	1283	1285
not	1287	1289
differ	1291	1296
with	1298	1301
respect	1303	1309
to	1311	1312
age	1314	1316
,	1317	1317
ISS	1319	1321
,	1322	1322
GCS	1324	1326
,	1327	1327
BE	1329	1330
,	1331	1331
ICP	1333	1335
days	1337	1340
,	1341	1341
24	1343	1344
-	1345	1345
h	1346	1346
transfusions	1348	1359
,	1360	1360
ICU	1362	1364
days	1366	1369
,	1370	1370
ventilator	1372	1381
days	1383	1386
,	1387	1387
head	1389	1392
AIS	1394	1396
,	1397	1397
or	1399	1400
length	1402	1407
of	1409	1410
stay	1412	1415
.	1416	1416

In	1418	1419
all	1421	1423
,	1424	1424
183	1426	1428
patients	1430	1437
were	1439	1442
identified	1444	1453
,	1454	1454
of	1456	1457
whom	1459	1462
28	1464	1465
died	1467	1470
within	1472	1477
seven	1479	1483
days	1485	1488
and	1490	1492
were	1494	1497
excluded	1499	1506
from	1508	1511
the	1513	1515
analysis	1517	1524
.	1525	1525

All	1527	1529
patients	1531	1538
were	1540	1543
followed	1545	1552
until	1554	1558
discharge	1560	1568
for	1570	1572
both	1574	1577
CNS	1579	1581
infections	1583	1592
and	1594	1596
subsequent	1598	1607
infectious	1609	1618
complications	1620	1632
.	1633	1633

Only	1635	1638
two	1640	1642
patients	1644	1651
,	1652	1652
both	1654	1657
in	1659	1660
the	1662	1664
PRO	1666	1668
group	1670	1674
,	1675	1675
developed	1677	1685
CNS	1687	1689
infection	1691	1699
.	1700	1700

Both	1702	1705
infectious	1707	1716
complications	1718	1730
(	1732	1732
0	1733	1733
.	1734	1734
7	1735	1735
vs	1737	1738
1	1740	1740
.	1741	1741
4	1742	1742
per	1744	1746
patient	1748	1754
;	1755	1755
p	1757	1757
<	1759	1759
0	1761	1761
.	1762	1762
05	1763	1764
)	1765	1765
and	1767	1769
infections	1771	1780
secondary	1782	1790
to	1792	1793
MDR	1795	1797
pathogens	1799	1807
(	1809	1809
0	1810	1810
.	1811	1811
03	1812	1813
vs	1815	1816
.	1817	1817
0	1819	1819
.	1820	1820
33	1821	1822
per	1824	1826
patient	1828	1834
;	1835	1835
p	1837	1837
<	1839	1839
0	1841	1841
.	1842	1842
01	1843	1844
)	1845	1845
were	1847	1850
significantly	1852	1864
more	1866	1869
common	1871	1876
in	1878	1879
the	1881	1883
PRO	1885	1887
group	1889	1893
.	1894	1894

Twenty	1896	1901
-	1902	1902
nine	1903	1906
percent	1908	1914
of	1916	1917
the	1919	1921
ventilator	1923	1932
-	1933	1933
associated	1934	1943
pneumonias	1945	1954
and	1956	1958
33	1960	1961
%	1962	1962
of	1964	1965
the	1967	1969
blood	1971	1975
stream	1977	1982
infections	1984	1993
in	1995	1996
the	1998	2000
PRO	2002	2004
group	2006	2010
were	2012	2015
MDR	2017	2019
,	2020	2020
whereas	2022	2028
only	2030	2033
two	2035	2037
blood	2039	2043
stream	2045	2050
infections	2052	2061
in	2063	2064
the	2066	2068
NONE	2070	2073
group	2075	2079
(	2081	2081
4	2082	2082
%	2083	2083
of	2085	2086
the	2088	2090
total	2092	2096
infections	2098	2107
)	2108	2108
were	2110	2113
MDR	2115	2117
.	2118	2118

The	2120	2122
routine	2124	2130
use	2132	2134
of	2136	2137
prophylactic	2139	2150
antibiotics	2152	2162
for	2164	2166
ICP	2168	2170
monitor	2172	2178
insertion	2180	2188
is	2190	2191
not	2193	2195
warranted	2197	2205
.	2206	2206

This	2208	2211
practice	2213	2220
does	2222	2225
not	2227	2229
reduce	2231	2236
the	2238	2240
CNS	2242	2244
infection	2246	2254
rate	2256	2259
and	2261	2263
is	2265	2266
associated	2268	2277
with	2279	2282
more	2284	2287
MDR	2289	2291
pathogens	2293	2301
in	2303	2304
any	2306	2308
subsequent	2310	2319
infectious	2321	2330
complications	2332	2344
.	2345	2345
